[1]吴卫元,杨永青.甲状腺激素在心血管疾病诊断和治疗中的临床应用[J].国际放射医学核医学杂志,2010,34(4):223-225.[doi:10.3760/cma.j.issn.1673-4114.2010.04.009]
　WU Wei-yuan,YANG Yong-qing.Clinical application of thyroid hormone in diagnosis and therapy on cardiovascular disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):223-225.[doi:10.3760/cma.j.issn.1673-4114.2010.04.009]
点击复制

甲状腺激素在心血管疾病诊断和治疗中的临床应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第4期
页码:
223-225
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Clinical application of thyroid hormone in diagnosis and therapy on cardiovascular disease
作者:
吴卫元1;  杨永青2
1. 215128, 苏州大学附属第一医院吴中分院检验科;
2. 215002, 苏州市立医院核医学科
Author(s):
WU Wei-yuan1;  YANG Yong-qing2
Department of Diagnosis, Wuzhong Branch, the First Hospital of Soochow University, Suzhou 215128, China
关键词:
心力衰竭; 充血性; 心肌梗死; 肺心病; 甲状腺激素类; 化学发光测定法
Keywords:
Heart failure; congestive; Myocardial infarction; Pulmonary heart disease; Thyroid hormones; Chemiluminescent measurements
DOI:
10.3760/cma.j.issn.1673-4114.2010.04.009
摘要:
目的 探讨甲状腺激素在心血管疾病诊断和治疗中的临床应用。方法 用发光免疫分析法150例冠心病心力衰竭患者,86例急性心肌梗死(AMI)患者,103例肺心病患者和47名我院健康体检者(正常对照组)血清中的甲状腺激素水平。结果 冠心病心力衰竭患者、AMI患者和肺心病患者血清中三碘甲腺原氨酸(T3)、游离三碘甲腺原氨酸(FT3)及T3/反转三碘甲腺原氨酸(rT3)较正常对照组明显降低(t=2.120、2.214、4.356,P均<0.05),而血清rT3明显增高(t=2.256、4.416、4.512,P均<0.05)。冠心病心力衰竭患者的血清T3、FT3及T3/rT3随心力衰竭的严重程度明显降低;肺心病急发期较缓解期降低明显,rT3则增加明显。冠心病心力衰竭患者、AMI患者和肺心病患者血清中甲状腺素、游离甲状腺素和促甲状腺激素与正常对照组比较无明显差异(t=1.781、1.813、1.754,P均>0.05)。结论 血清T3、FT3和T3/rT3的降低和rT3的增高是诊断冠心病心力衰竭及严重程度、AMI和肺心病急发期或缓解期的有效指标,并具有治疗后随访的临床价值。
Abstract:
Objective To study clinical application of sera thyroid hormone in diagnosis and therapy on cornary heart disease(CHD)heart failure, acute myocardial infarction(AMI) and pulmonary heart disease.Methods Determined the changes of serum triiodothyronine(T3), tetraiodothyronine(T4), free triiodothyronine (FT3), free tetraiodothyronine(FT4), thyroidstimulating hormone(TSH), reverse triiodothyronine (rT3) and T3/rT3 levels in 150 cases patients with CHD heart failure, 86 cases patients with AMI, 103 cases patients with pulmonary heart disease and 47 cases normal controls by chemiluminescent measurement. Results The serum levels of T3, T4, FT3, FT4, TSH, rT3 and T3/rT3 in CHD heart failure, AMI pulmonary heart disease were compared with normal controls. Serum T4, FT4 and TSH levels were not different between above patients and normal controls(t=2.120, 2.214, 4.356, P<0.05), but the serum T3, FFT3 and T3/rT3 were significantly decreased than those of normal controls(t=2.256, 4.416, 4.512, P<0.05). The serum rT3 levels were significantly increased those of than normal controls (t=1.781, 1.813, 1.754, P>0.05). The serum T3, FT3 and T3/rT3 levels were significantly decreased in patient with CHD heart failure severity. But the serum rT3 levels was significantly increased. Conclusion The present study showed that change of serum T3, FT3 and T3/rT3 levels in patients with CHD heart failure, AMI and pulmonary heart disease were inpartant marker and could reflect the severity of disease and used as diagnostic or treatment indicators.

参考文献/References:

[1] Opasich C,Pacini F,Ambrosino N,et al.Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure.Eur Heart J,1996,17(12):1860-1866.
[2] 杜馥曼,刘彤梅,王嵬民.血清甲状腺素水平与心力衰竭关系分析.放射免疫学杂志,2006,19(3):205-206.
[3] Hamilton MA,Stevenson LW,Fonarow GC,et al.Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure.Am J Cardiol,1998,81(4):443-447.
[4] Chodosh S.Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis.Cheat,2005,127(6):2231-2236.
[5] 毛庆民,毛鑫,张新庆.血清甲状腺激素检测在肺心病患者诊断与治疗中的应用.放射免疫学杂志,2008,21(2):140.

相似文献/References:

[1]李殿富,袁冬兰,曹克将,等.门控心肌灌注SPECT相位分析技术评价心力衰竭患者左室不同步的价值[J].国际放射医学核医学杂志,2010,34(1):38.[doi:10.3760/cma.j.issn.1673-4114.2010.01.010]
　LI Dian-fu,YUA N Dong-lan,CAO Ke-jiang,et al.The value of phase analysis of gated myocardial perfusion SPECT to assess left ventricular dyssynchrony[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):38.[doi:10.3760/cma.j.issn.1673-4114.2010.01.010]
[2]王曼.放射性核素显像在心力衰竭中的应用[J].国际放射医学核医学杂志,2002,26(6):268.
　WANG Man.Application of radionuclide imaging in heart failure[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):268.
[3]郑青,鲍逸民,杨永青.慢性心力衰竭患者血脂、血浆NT-ProBNP、CTnⅠ和hs-CRP水平测定的临床分析[J].国际放射医学核医学杂志,2014,38(4):232.[doi:10.3760/cma.j.issn.1673-4114.2014.04.006]
　Zheng Qing,Bao Yimin,Yang Yongqing.The clinical analysis of blood lipid and plasma NT-proBNP, CTnⅠ and hs-CRP levels determined in patients with chronic heart failure[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):232.[doi:10.3760/cma.j.issn.1673-4114.2014.04.006]
[4]韩磊,石洪成.核心脏病学在心力衰竭中的临床应用[J].国际放射医学核医学杂志,2011,35(3):158.[doi:10.3760/cma.j.issn.1673-4114.2011.03.007]
　HAN Lei,SHI Hong-cheng.Clinical use of nuclear cardiology in the assessment of heart failure[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):158.[doi:10.3760/cma.j.issn.1673-4114.2011.03.007]
[5]刘义明,揭育丽.充血性心力衰竭患者肾上腺髓质素与内皮素、血管紧张素Ⅱ结果比较[J].国际放射医学核医学杂志,2007,31(2):96.
　LIU Yi-ming,JIE Yu-li.A comparision between adrenomedullin, endothelin and angiotensin Ⅱ in patients with congestive heart failure[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):96.

备注/Memo

备注/Memo:
收稿日期:2009-10-18。
通讯作者:杨永青,E-mail:SZWZWWY@eohu.com.cn
更新日期/Last Update: 1900-01-01